Received Dec 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z009470 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No additional AE; Pharmacist stated that a dose of VARIVAX was administered to a patient after being exposed to a temperature excursion on 10/31/2025.; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not provided. On 31-Oct-2025, the patient was vaccinated with an improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (involved lot # was Z009470, expiration date: 27-May-2027 [verified to be valid]); 0.5 ml/ two dose series, administered for prophylaxis (strength, and route of administration were not provided). Temperature excursion and time frame were not provided. There was no report of adverse effect or product quality complaint involved.